Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

BMJ · 1994 · 3.1K citations

Warfarin, Aspirin, or Both after Myocardial Infarction

Mette Hurlen, Michael Abdelnoor, Pål Smith et al. · New England Journal of Medicine · 2002 · 847 citations

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

Patricia A. Gum, Kandice Kottke‐Marchant, Emilio Poggio et al. · The American Journal of Cardiology · 2001 · 820 citations

Thrombosis, Aspirin Resistance, Cardiovascular Epidemiology +9

Development of aspirin resistance in persons with previous ischemic stroke.

Cathy M. Helgason, Kristian Bolin, Julie Hoff et al. · Stroke · 1994 · 411 citations